DDD vs SSYS

3D Systems continues to operate in a high-growth TAM (medical/industrial 3D printing) with strategic focus and existing IP. However, its financial health remains critically weak, marked by ongoing revenue decline and persistent unprofitability, making a clear path to scalable growth and sustainable profitability elusive within our 3-5 year window. While leadership continues its pivot, tangible exe...

Stratasys (SSYS) still presents a high-risk, low-reward profile for 10x growth potential, with a slight adjustment from the previous analysis. While Q4 2025 revenue declined -6.9% YoY, the company reported a positive EPS of $0.07, beating estimates, which is a minor positive against previous concerns of worsening unprofitability for that specific quarter. New product launches (PolyJet J850 Core, G...